Cargando…
Nanobiosystems for Antimicrobial Drug-Resistant Infections
The worldwide increased bacterial resistance toward antimicrobial therapeutics has led investigators to search for new therapeutic options. Some of the options currently exploited to treat drug-resistant infections include drug-associated nanosystems. Additionally, the use of bacteriophages alone or...
Autores principales: | Gkartziou, Foteini, Giormezis, Nikolaos, Spiliopoulou, Iris, Antimisiaris, Sophia G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143556/ https://www.ncbi.nlm.nih.gov/pubmed/33922004 http://dx.doi.org/10.3390/nano11051075 |
Ejemplares similares
-
In Vitro Anti-Biofilm Activity of Bacteriophage K (ATCC 19685-B1) and Daptomycin against Staphylococci
por: Plota, Maria, et al.
Publicado: (2021) -
Moxifloxacin Liposomes: Effect of Liposome Preparation Method on Physicochemical Properties and Antimicrobial Activity against Staphylococcus epidermidis
por: Natsaridis, Evangelos, et al.
Publicado: (2022) -
Therapeutic impacts of enzyme-responsive smart nanobiosystems
por: Fathi, Marziyeh, et al.
Publicado: (2020) -
Liposomal Entrapment or Chemical Modification of Relaxin2 for Prolongation of Its Stability and Biological Activity
por: Kogkos, George, et al.
Publicado: (2022) -
Clonal dissemination and resistance genes among Stenotrophomonas maltophilia in a Greek University Hospital during a four-year period
por: Papadimitriou-Olivgeris, Matthaios, et al.
Publicado: (2022)